Pathogenicity of non-albicans yeasts in the vagina

Journal of Lower Genital Tract Disease

Volumn 15, Issue 1, 2011, Pages 33-36

  Dennerstein, Graeme J ^a   Ellis, David H ^b   Reed, Caroline S ^c   Bennett, Catherine M ^d  

^a Western Health Sunshine Hospital   (United States)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c Dorevitch Pathology   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Candida glabrata; Non albicans yeasts; vaginal yeast pathogenicity; vulvovaginal candidiasis

Indexed keywords

AMITRIPTYLINE; ANTIINFECTIVE AGENT; BORIC ACID; MEDROXYPROGESTERONE ACETATE; STEROID;

ADULT; ARTICLE; AUSTRALIA; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CASE CONTROL STUDY; COMORBIDITY; CONTROLLED STUDY; FEMALE; FUNGAL VIRULENCE; FUNGUS CULTURE; FUNGUS IDENTIFICATION; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; OUTCOME ASSESSMENT; PATIENT COUNSELING; PROSPECTIVE STUDY; PSYCHOTHERAPY; VAGINA CANDIDIASIS; VAGINAL PRURITUS; VULVOVAGINAL DISCOMFORT;

ADULT; AGED, 80 AND OVER; AUSTRALIA; CASE-CONTROL STUDIES; FEMALE; HUMANS; MIDDLE AGED; MYCOSES; PREGNANCY; TREATMENT OUTCOME; VULVOVAGINITIS; YEASTS;

EID: 78651373183     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/LGT.0b013e3181d94f39     Document Type: Article

References (12)

1. Agatensi L, Franchi F, Mondello F, Bevilacqua RL, Ceddia T, De Bernardis F, et al. Vaginopathic and proteolytic Candida species in outpatients attending a gynaecology clinic. J Clin Pathol 1991;44:826-30.
2. Dennerstein GJ, Ellis DH. Oestrogen, glycogen and vaginal candidiasis. Aust N Z J Obstet Gynaecol 2001;41: 326-8.
3. Dennerstein GJ, Scurry J, Brenan J, Allen D, Marin M-G. The Vulva and Vagina Manual. Melbourne, Australia: Gynederm Publishing; 2005.
4. Singh S, Sobel JD, Bhargava P, Boikov D, Vasquez JA. Vaginitis due to Candida krusei: epidemiology, clinical aspects and therapy. Clin Infect Dis 2002;35:1066-70.
5. Sobel JD, Chaim W, Nagappan V, Leaman D. Treat-ment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine. Am J Obstet Gynecol 2003;189: 1297-300.
6. Sobel JD, Chaim W. Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy. Clin Infect Dis 1997;24:649-52.
7. Spinillo A, Capuzzo E, Gulminette R, Marone P, Colonna L, Piazza G. Prevalence of and risk factors for fungal vaginitis caused by non-albicans species. Am J Obstet Gynecol 1997;176:135-41.
8. Richter SS, Galask RP, Messer SA, Hollis RL, Diekema DL, Pfaller MA. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol 2005;43:2155-62.
9. Dennerstein GJ. The cytology of the vulva. J Obstet Gynaecol Br Commonw 1968;75:603-9.
10. Dennerstein GJ. Diagnosis of vaginal discharges: another approach to an old problem. Med J Aust 1970;1: 992-4.
11. Dennerstein GJ. Cytology in the differential diagnosis of vaginitis. Curr Infect Dis Rep 2008;10:485-89.
12. Gardner HL, Kaufman RH. Benign Diseases of the Vulva and Vagina. St Louis, MO: CV Mosby Company; 1969.